Verrica Pharmaceuticals Inc. logo

VRCAVerrica Pharmaceuticals Inc.

VRCA Stock Price, Valuation & Chart | Verrica Pharmaceuticals Inc.

Compare

VRCA Historical price chart

VRCA Key Stats

Fair Value
Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Market Capitalization92.59M
PE Ratio-6.57
EPS-0.82
Trading Volume30.16K
Today's High/Low5.57/5.28
Dividend Yield0.00
52 Week High/Low9.82/3.28
Shares Outstanding17.18M
VRCA Financial Statement
VRCA Analyst ratings
VRCA Analysis & performance metrics

VRCA Company profile

Verrica Pharmaceuticals Inc., a dermatology therapeutics company, develops and commercializes treatments for people with skin diseases in the United States. The company's…

VRCA Management team

Management
David ZawitzCOO
Chief Operating Officer
Bradley J. Catalone MBA, Ph.D.
Head of Drug Development
John J. Kirby CPACFO
Interim Chief Financial Officer
Eugene Scavola
Executive Vice President of Technical Operations
Noah L. Rosenberg M.D.
Chief Medical Officer
Jayson M. Rieger M.B.A., Ph.D.CEO
President, Chief Executive Officer & Director
Total 6 executives

VRCA Frequently asked questions

What is Verrica Pharmaceuticals Inc. (VRCA) Stock Price?

Current stock price of Verrica Pharmaceuticals Inc. (VRCA) stock is $5.390. The stock price is +2.86% higher in the session. The intraday range can be seen from this page. Volume of Verrica Pharmaceuticals Inc. (VRCA) stock is 30.16K.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the Verrica Pharmaceuticals Inc. (VRCA) stock price going up or down today?

The stock price of Verrica Pharmaceuticals Inc. (VRCA) can change with earnings, company news, and overall market sentiment. Verrica Pharmaceuticals Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Verrica Pharmaceuticals Inc. stock expensive at its current price?

Whether Verrica Pharmaceuticals Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for VRCA on this page is -6.57. EPS on this page is -0.82. Compare those figures with peers and growth expectations before deciding if the current Verrica Pharmaceuticals Inc. price is justified.

How has the stock price of Verrica Pharmaceuticals Inc. (VRCA) performed historically?

Historical performance for Verrica Pharmaceuticals Inc. (VRCA) is shown on the price chart on this page. Review multi-period moves alongside volume to see how VRCA reacted to past earnings and market events.

Should I buy Verrica Pharmaceuticals Inc. (VRCA) stock, at this price?

Buying Verrica Pharmaceuticals Inc. (VRCA) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.